Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside

• click to rate

  Posted by Two Blokes Jun 23 - Filed in Stock - 3 views
  
  On Monday, HC Wainwright initiated coverage on Septerna, Inc. SEPN, citing a next-generation drug design platform aimed at hitherto-undruggable targets.